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Abstract
Background: Individuals living in sub-Saharan Africa represent 10% of the world’s population but almost 2/3 of all HIV-1/
AIDS cases. The disproportionate HIV-1 infection rates in this region may be linked to helminthic parasite infections that
affect many individuals in the developing world. However, the hypothesis that parasite infection increases an individual’s
susceptibility to HIV-1 has never been prospectively tested in a relevant in vivo model.
Methodology/Principal Findings: We measured whether pre-existing infection of rhesus monkeys with a parasitic worm
would facilitate systemic infection after mucosal AIDS virus exposure. Two groups of animals, one consisting of normal
monkeys and the other harboring Schistosoma mansoni, were challenged intrarectally with decreasing doses of R5-tropic
clade C simian-human immunodeficiency virus (SHIV-C). Systemic infection occurred in parasitized monkeys at viral doses
that remained sub-infectious in normal hosts. In fact, the 50% animal infectious (AID50) SHIV-C dose was 17-fold lower in
parasitized animals compared to controls (P,0.001). Coinfected animals also had significantly higher peak viral RNA loads
than controls (P,0.001), as well as increased viral replication in CD4
+ central memory cells (P=0.03).
Conclusions/Significance: Our data provide the first direct evidence that acute schistosomiasis significantly increases the
risk of de novo AIDS virus acquisition, and the magnitude of the effect suggests that control of helminth infections may be a
useful public health intervention to help decrease the spread of HIV-1.
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Introduction
Sub-Saharan Africa represents only 10% of the world’s
population but more than 62% of the world’s HIV/AIDS cases
[1]. While it remains controversial whether HIV transmission
and/or disease progression in sub-Saharan Africa differ from what
is observed in industrialized countries [2], one factor that may
contribute to any exacerbation of HIV/AIDS is the high
prevalence of parasitic worm infections, such as schistosomiasis
[3,4]. However, because it is not possible to directly test this
hypothesis in humans, studies to date have evaluated in vitro
exposure of cells to virus [5,6], effects of schistosome infection on
established viral infection [7,8], or epidemiologic evaluations of
the effect of praziquantel treatment on viral load [9–12]. None of
these approaches address the issue of whether a helminth infection
increases the susceptibility of the host to acquire de novo infection
with an immunodeficiency virus after mucosal exposure, the
predominant route of HIV transmission in humans.
In order to directly investigate this essential question, we tested
the effect of Schistosoma mansoni infection on host susceptibility to
immunodeficiency virus infection using schistosome-infected and
control macaques exposed intrarectally to successively lower doses
of the recently described R5-tropic SHIV-C, SHIV-1157ipd3N4
[13]. This strain is highly relevant for our study because an
estimated 90% of all new HIV-1 infections occur by mucosal
transmission, which almost exclusively involves R5 strains [14],
and clade C strains cause .50% of all HIV-1 infections worldwide
[1]. We also assessed the impact of schistosome infection on viral
loads and immune cell profiles in monkeys with SHIV infection.
These studies represent the first prospective evaluation of the
impact of helminth infection on immunodeficiency virus trans-
mission in a relevant model.
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Animals
Chinese-origin adult female rhesus macaques were housed at the
animal facility of the Centers for Disease Control and Prevention
(CDC) in Atlanta, GA. Protocols were approved and animals were
maintained in accordance with the guidelines of the Institution
Animal Care and Use Committees for both CDC and the Dana-
Farber Cancer Institute (DFCI). All procedures employed were
consistent with the Guide for Care and Use of Laboratory Animals.
Animals were free of helminth infection prior to our study.
Virus
SHIV-1157ipd3N4 [13], an R5-tropic SHIV-C infectious
molecular clone, is a monkey-adapted, late form of SHIV-1157i,
which encodes most of the env sequences of a primary HIV-1 clade
C strain isolated from a recently infected Zambian infant. SHIV-
1157ipd3N4 was engineered with an additional NF-kB site per
long terminal repeat (LTR) in order to enhance viral replication.
The methodology used to construct this virus as well as its parental
biologic strains are described by Song et al. [13]. Both the early
and the late forms of our SHIV-C were pathogenic in rhesus
monkeys, although disease progression was somewhat slow, with
AIDS developing approximately 2.5–5.5 years post-inoculation.
Rectal SHIV-1157ipd3N4 inoculation
Animals were anesthetized with ketamine and placed in a prone
position. SHIV-1157ipd3N4 dilutions were prepared in RPMI in a
total volume of 1 ml. The inoculum wasloaded into a gastricfeeding
tube and inserted 5 cm into the rectum with the aid of lubricant.
Animals were infused with 1 ml of the virus dilution followed by
3 ml of plain RPMI and 2 ml of air. All animals were exposed to
virus dilution within 1 hr after the vial of stock virus was thawed.
S. mansoni infections
Animals were anesthetized with ketamine and percutaneously
exposed to 500 cercariae of a Puerto Rican strain of S. mansoni.A n
area on the abdomen was shaved, and cercariae were placed on
the skin within a metal ring for 30 min to allow penetration. To
monitor infection, fresh stool was obtained and processed by
formalin-ethylacetate sedimentation and concentration.Schistosome
eggs were counted by microscopic examination. White blood cell
counts(WBC)andpercenteosinophilswerecalculatedusingstandard
Author Summary
To test the hypothesis that infection with helmiths may
increase host susceptibility to infection with HIV-1, we
quantified the amount of a clade C simian-human
immunodeficiency virus needed to infect rhesus macaques
that had acute Schistosoma mansoni infections. Compared
to control animals exposed to virus alone, monkeys with
schistosomiasis required exposure to 17-fold lower levels
of virus to become infected. The schistosome-infected
monkeys also had significantly higher levels of initial virus
replication and loss of a certain subset of memory T cells,
both predictors of a more rapid progression to immune
dysfunction. These results suggest that worm infections
may increase the risk of becoming infected with HIV-1
among individuals with viral exposures. Furthermore, they
support the idea that control programs for schistosomiasis
and perhaps other parasitic worm infections may also be
useful in helping to reduce the spread of HIV/AIDS in
developing countries where helminths are endemic.
Table 1. SHIV-1157ipd3N4 titration.
Animal Virus Dilution Systemic infection Peak viral RNA load (copies/ml610
6)A I D 50 95% CI (P)
Parasite-free Neat + 1.3
1:5?5* + 2.1
1:10 + 3.4
1:50 + 8.2
1:50 + 3.0
1:50 2
1:60 2
1:100 2
1:300 2
1:1000* 2
Median: 3.0 1:40 1:11 to 1:143
S. mansoni+ 1:50 + 20.6
1:60 + 154.2
1:100 + 70.3
1:300 + 31.4
1:300 + 34.6
1:300 + 8.4
1:500 2
1:5000 2
Median: 33.0 1:714 1:200 to 1:2500 (P,0.001)
*This animal was first exposed to a 1:1000 dilution of the virus. When it was not infected, the monkey was re-exposed to a 1:5.5 dilution of virus, which was infective.
doi:10.1371/journal.pntd.0000265.t001
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and ratios were determined by the Pathology Laboratory at Yerkes
National Primate Research Center (Atlanta, GA). There was no
evidence of fever, diarrhea, weight loss, or dysentery in these animals.
Quantitation of viral RNA (vRNA) loads and simian
cytokine mRNAs
Peripheral blood samples were obtained by venipuncture and
collected into Vacutainer cell preparation tubes containing sodium
citrate (Becton Dickinson, Rutherford, N.J.). Immediately after
collection, plasma and PBMC were separated and quick frozen.
Plasma samples from infected monkeys were stored at 280uCu n t i l
vRNA loads were assessed by real-time RT-PCR [15]. Cells were
washed once in RPMI 1640 (Gibco, Grand Island, NY), lysed with
RLT lysis buffer (Qiagen, Valencia, CA) containing 1% b-
mercaptoethanol (Sigma Chemical Company, St. Louis, MO), and
stored at 280uC until they were processed to measure cytokine
mRNA levels. A quantitative real-time RT-PCR assay based on
TaqMan chemistry was utilized to measure mRNA levels for the
cytokines interleukin IL-2, IL-4, IL-6, IL-10, IFN-c,a n dT N F - a and
the chemokine RANTES using previously described primers and
protocols [16]. mRNA expression was normalized using primers
uniquefor the housekeeping gene,phosphatedehydrogenase (PDH).
Phenotyping and cell sorting
The following antibodies were used for both phenotyping and
sorting of peripheral blood mononuclear cells (PBMC): CD3-
Alexa700, CD4-PERCP-Cy5.5, CD8-APC-Cy7, CCR7-FITC,
CD45RA-ECD, CD28-PE, CD95-APC; for cell sorting, we stained
PBMC for CD4+ T-cell subsets only, using CD3, CD4, CD28 and
CD95 mAbs. All reagents, except for CCR7 (R&D Systems,
Minneapolis, MN), were obtained from BD Biosciences (San Jose,
CA). For phenotyping and/or cell sorting, PBMC were isolated
from blood collected and separated in Na citrate CPT tubes (Becton
Dickinson). Cells were washed, counted, and resuspended in
phosphate-buffered saline (PBS) containing 2% FCS with the
appropriate mix of antibodies. For phenotyping, 2610
6 cells were
stained, for cell sorting, a minimum of 10610
6 cells were evaluated.
Following incubation with antibodies for 15 min under reduced
light, cells were washed and resuspended in PBS containing 1%
paraformaldehyde prior to analysis. Data were collected on a
Becton Dickinson cell sorter FACSVantage with DiVa option (BD
Biosciences) and analyzed with FlowJo analysis software (Tree Star,
Inc., Ashland, OR). In both cases, we used an electronic gate on the
forward scatter (FSC-H/FSC-A) to avoid doublets.
Statistical analyses
Calculation of AID50 values and statistical comparison of
infectious doses were performed using the method of Spouge [17].
Peak vRNA loads and single time point T-cell subsets were
compared using the Wilcoxon rank-sum test. Statistical compar-
isons of vRNA loads and T-cell subsets over time between
schistosome-infected and parasite-free groups were performed
using repeated measures analysis. Modeling was performed with
generalized estimating equations [18].
Results
S. mansoni infection significantly decreases the SHIV-C
viral dose required to establish systemic infection
After preparation and storage of multiple vials of a large SHIV-
C (strain SHIV-1157ipd3N4) stock, the minimal and AID50
necessary to establish systemic viral infection after mucosal
challenge were determined in a group of 9 parasite-free animals
(Table 1). Plasma vRNA loads were monitored prospectively by
real-time RT-PCR (15). The minimal infectious dose for the
parasite-free controls was 1 ml of virus stock diluted 1:50; only 2 of
the 3 animals exposed to this dilution became systemically
infected. Based on the statistical method of Spouge [17], we
determined that the AID50 of SHIV-C was 0.025 ml (95%
confidence interval (CI), 7610
23 to 8.7610
22) for these control
animals.
To evaluate the impact of helminth infection on the
susceptibility to SHIV-C, a second group of 8 macaques was
infected with schistosomes by percutaneous exposure to 500
cercariae. Parasite infection was confirmed by measuring signs
consistent with acute schistosomiasis: egg excretion in feces,
eosinophilia (Figure 1A), and increased PBMC IL-4 mRNA levels
(Figure 1B). In contrast, mRNA levels for IL-2, IL-6, IFN-c,
TNF-a, and RANTES did not differ between baseline and week
7 after infection (data not shown). Levels of IL-10 mRNA were
increased as a result of schistosome infection at week 7 but were
not statistically different. However, by 14 weeks of schistosome
Figure 1. Parasitologic and immunologic changes in rhesus
macaques infected with Schistosoma mansoni. (A) Eggs per gram
feces in stool samples and percent eosinophils in blood from monkeys
that were infected with S. mansoni; (B) IL-4 mRNA expression in PBMC of
all S. mansoni-positive rhesus monkeys prior to exposure to SHIV-C. The
ratios of IL-4 mRNA copies to mRNA copies of the housekeeping gene
PDH are shown. Lines represent group medians. Statistical analysis of
data in panel B was performed using the Wilcoxon rank-sum test.
doi:10.1371/journal.pntd.0000265.g001
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mRNA was statistically significant (p=0.047) compared to
baseline. Monkeys were exposed to SHIV-C between 7 and 9
weeks after schistosome infection. The minimal infectious dose in
animals with schistosomiasis was 1 ml of SHIV-C diluted 1:300;
all 3 animals exposed to this dose became systemically infected
(Table 1). The AID50 for animals with schistosomiasis (0.0014 ml,
95% CI, 4610
24 to 5610
23) was 17-fold lower than that for
parasite-free animals (P,0.001). The minimal infectious virus
dose differed by a factor of 6 between the two groups of monkeys.
S. mansoni infection significantly increases SHIV-C
replication and host immune activation
The mean peak vRNA load was .1 log higher in animals with
acute schistosomiasis than in controls (P,0.001) even though the
mean viral inoculum that led to systemic infection in animals with
schistosomiasis (1:185) was lower than that in parasite-free controls
(1:23) (Figure 2A). This is consistent with our previous findings that
the magnitude of the peak vRNA load in infected animals depends
on host factors and not on the viral concentration of the inoculum
[19]. Elevated vRNA loads in parasite-infected animals were
maintained through 10 weeks after virus exposure (P,0.001)
(Figure 2B), similar to the elevated viral replication we observed in
schistosome-infected animals that had been exposed intravenously
to equal, high doses of a related SHIV [7].
Although vRNA loads were higher in animals with schistoso-
miasis, levels of both CD4
+ (Figure 2C) and CD8
+ (Figure 2D) T
cells were also elevated in these animals compared to virus-only
controls, consistent with the generalized immune activation caused
by schistosomiasis. CD4/CD8 ratios were similar between the two
groups and remained steady over time (data not shown).
Increased viral replication in CD4+ central memory T cells
of coinfected animals
PBMC from coinfected monkeys and from animals infected
with SHIV-C alone were analyzed by multi-color flow cytometry
after a month of viral inoculation (Figure 3A). The levels of CD4
+
central memory (CM) T cells were significantly higher in
coinfected animals, while parasite-free animals had more naı ¨ve
CD4
+ T cells (Figure 3B). We observed a similar pattern in CD8
+
naı ¨ve and memory T cells but these differences were not
statistically significant (data not shown).
Figure 2. Virology and T cell subsets of schistosome infected and control animals following exposure to SHIV-C. (A) Peak vRNA loads
(week 2 post-inoculation) and (B) longitudinal vRNA loads in coinfected and parasite-free monkeys. (C) CD4
+ and (D) CD8
+ T cells in coinfected and
parasite-free monkeys. Lines in panel (A) represent group medians. For panels (B), (C) and (D), points represent group means and error bars represent
standard deviations. Statistical analysis of data in panel A was performed using the Wilcoxon rank-sum test. Data in panels B–D were analyzed using
repeated measures analysis and generalized estimating equations to compare the data over time for the two groups.
doi:10.1371/journal.pntd.0000265.g002
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+ T cell subsets and cell viral loads between animals with S. mansoni/SHIV-C coinfection and SHIV-C
infection alone. (A) Phenotyping strategy used to separate naı ¨ve, central memory (CM), effector memory (EM) and effector memory CD45RA
+
(EMRA) T cell subsets. Percentages demonstrate T cell subsets for one of the coinfected monkeys. (B) CD4
+ naı ¨ve, CM and EM in coinfected and
parasite-free monkeys. (C) SHIV-C RNA detected in CD4
+ naı ¨ve, CM, and EM T cells after sorting. For panels (B) and (C), group means and standard
deviations are represented.
doi:10.1371/journal.pntd.0000265.g003
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different CD4
+ T-cell subsets. We sorted CD4
+ naı ¨ve and
memory T-cell subsets for each group of animals (Figure 3A)
and determined vRNA levels by RT-PCR (Figure 3C). Both
naı ¨ve and memory CD4
+ T cells from coinfected animals
contained more vRNA per 10
6 cells than the corresponding cells
of animals infected with SHIV-C alone; the difference was
statistically significant only in CD4
+ CM subset (CD28
+ CD95
+)
of T cells (P=0.03) (Figure 3C). Consistent with the higher
vRNA levels in CD4
+ CM T cells of coinfected animals, 4 out of
the 6 of these monkeys also had losses to abnormal levels
(,10%) of the CD4
+CD29
+ subset of memory T-cells in
peripheral blood, which is an early sign of immune dysfunction
in lentivirus-infected-macaques [13,20,21]. In contrast, none of
the 5 animals infected with virus alone fell below this threshold
(data not shown). Together, these results suggest that CD4
+ T
cells from coinfected animals are more permissive to viral
infection and replication, leading to more rapid destruction of
memory T cells.
Discussion
This study is the first direct evidence showing that helminth
infection significantly increases host susceptibility to mucosal
AIDS virus transmission in primates. Systemic infection of S.
mansoni-infected rhesus macaques was established by low doses of
virus that remained sub-infectious in parasite-free hosts, and the
difference in viral dose needed to successfully establish systemic
infection was surprisingly large. Furthermore, peak vRNA levels
were also significantly elevated in schistosome-infected monkeys,
consistent with previous in vitro, epidemiologic and primate model
studies that suggest increased viral replication in schistosome-
infected hosts or cells from persons with helminth infections [5–9].
However, none of the earlier studies was able to address whether
schistosome infection increased the likelihood of de novo immuno-
deficiency virus infection in hosts harboring helminths. The
increased susceptibility to mucosal immunodeficiency virus
transmission we observed in schistosome-infected macaques,
elevated viral replication in coinfected hosts, and accelerated loss
of memory T cells all have profound public health implications for
areas of the world where both parasitic worms and HIV-1 are
endemic. Our data support the suggestion that better control of
helminth infections may favorably impact efforts to reduce the
spread of HIV/AIDS [3,4].
Ourobservationsareconsistent with thehypothesis that helminth
infections increase a hosts’ susceptibility to infection with immuno-
deficiency viruses and is associated with a Th2-type immunologic
phenotype and increased viral replication within these cells [22].
However, it is possible that any infection resulting in systemic
immune activation or increased peripheral blood CD4
+ T cell
numbers (Figure 2C) would have yielded similar results [23]. Other
data to support the hypothesis that Th2-type responses increase
susceptibility to virus infection include the observation that PBMC
from Kenyan schistosomiasis patients with HIV-1 coinfection
produce decreased levels of IL-4 and IL-10 compared to patients
with schistosomiasis alone. The magnitude of this effect correlates
with the decrease in CD4
+ T cells [24], suggesting that it is the
CD4
+ Th2 cells that are preferentially infected and killed by the
virus. Alternatively, the shift to a predominant Th2-type response in
schistosome-infected hosts may result in down-regulation of virus-
controlling cytotoxic T lymphocytes [25]. We will evaluate these
possibilities more directly in future studies.
We also considered whether the biology of parasite egg
excretion, combined with the rectal route of viral exposure, may
have increased host susceptibility to virus. Fecal egg excretion in
hosts infected with S. mansoni or S. japonicum increases the number
of activated T cells associated with egg granulomas that are in
close juxtaposition to the intestinal lining [26]. Furthermore, the
passage of eggs from mucosal tissue into the gut lumen may
compromise the integrity of the epithelial lining, which in turn
could lead to microbial translocation, release of immune-activating
bacterial products into the bloodstream, and facilitate intrarectal
SHIV-C transmission.
A limitation of our primate system is that we are only able to
model the effect of the acute phase of schistosomiasis on
susceptibility to viral transmission. This is because rhesus monkeys,
while able to develop a fully patent infection, self cure their
schistosomiasis at 20 to 25 weeks after exposure to cercariae
[7,8,27]. Thus, we were not able to assess whether animals exposed
to immunodeficiency virus during the chronic, more immunolog-
ically regulated phase of schistosome infection similarly display
increased susceptibility to viral transmission. If the increased
susceptibility to viral infection is related to the shift towards a
Th2-type immune response, the increase in susceptibility to virus
maybemore modestduringchronicinfectionswhen the phenotypic
shift is less dramatic. Nevertheless, in human hosts with chronic
schistosomiasis, both the immunologic stimulation and Th2-type
responses (e.g., eosinophilia) persist. In addition, surface levels of the
chemokine coreceptors CCR5 and CXCR4 are elevated on CD4
+
T cells and monocytes of persons with chronic schistosomiasis and
decrease following praziquantel treatment [28].
Our data strengthen the hypothesis that helminth infection may
be a risk factor for increased susceptibility to de novo HIV-1
infection and support control of schistosomiasis and perhaps other
helminths in persons living in areas endemic for these parasites. In
the absence of an effective AIDS vaccine, there are several other
strategies that may help decrease the risk of HIV-1 transmission,
including control of sexually transmitted diseases [29] and male
circumcision [30,31]. Treatment of helminth infections is
inexpensive, safe, and easily administered to large populations.
In addition to the benefit of reducing host morbidity caused by the
parasites, our data support control of helminths as a public health
intervention for individuals at risk for acquiring HIV-1.
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